PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
about
Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.Transcriptional inhibition of intestinal NHE8 expression by glucocorticoids involves Pax5.Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3.The role of the c-Met pathway in lung cancer and the potential for targeted therapy.Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer.MET as a possible target for non-small-cell lung cancer.Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expressionUpregulation of Human ST8Sia VI (α2,8-Sialyltransferase) Gene Expression by Physcion in SK-N-BE(2)-C Human Neuroblastoma Cells.PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.The molecular pathogenesis and management of bronchial carcinoids.Differential expression of RON in small and non-small cell lung cancers.PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines.Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype.PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].[Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models.Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer.Deacetylase activity-independent transcriptional activation by HDAC2 during TPA-induced HL-60 cell differentiation
P2860
Q26748581-BEE8CC99-E488-4F3B-9935-65772E22D6FFQ31154012-1EDBC4BF-91CB-4F11-8065-7A704B840DDFQ34182679-34DA7E7C-DD41-457F-9E4E-2C7D37FC7967Q34212100-A7E5B03D-F308-4331-9CD5-2028AAAD945AQ34949789-BE338192-E6CF-4455-8B39-9BDCAF2B5381Q35146937-280BA284-9134-4BA0-B0FD-2F59133CDBE4Q36464585-1B909EE8-B419-4397-B174-EF5AA32AEE0FQ36660673-C5F3A1E3-5161-4DD9-B864-EBB68E72650FQ36797506-AA817877-6074-41A5-86A9-8386B26CB0A7Q37209960-4D356551-C9DF-4D9A-B1C4-1EACCDD99A95Q37252398-A716C91A-A71E-4EA5-A5FE-2976E1EAAF78Q37707044-59324E20-6978-4D3F-99FE-F54CCBC0E789Q37775841-B31C88EC-C349-4910-B4BD-D14C117D9B6EQ37833109-E02B0520-FDCD-47E1-A4B7-FB209AD14F96Q38403475-0DA6C930-0BE6-4070-BD59-DB66C4E0BC43Q38846778-12AE3262-31B4-436D-BFC2-9DADDA0602C6Q38941113-5CF415C9-B99B-4583-BA82-ACFC6B554B19Q39101593-66B7E6FD-22FA-4FA0-A1E1-C5042E16787BQ39296297-BC6E1C27-8788-430F-9DF5-33E4118B773DQ39439183-F51DD93B-0F00-4ECA-8787-BB122BA0DA19Q42651022-52B917AF-2FA7-4B16-AD90-01DAA851BE3DQ46591244-E6B79FC0-99E3-4629-9BDC-CE3FA3DB837BQ48368856-C1D0019E-EA92-424A-8667-1A38B23E1D7EQ53232399-DB27FE76-5844-4FAA-B15B-A7408F858FB1Q53512514-FE5143C0-36E9-4F46-92D6-F9CBC5076E55Q53682879-56BB321B-1D55-4140-82A6-E6197732FAF0Q55110585-104D8981-C5C3-41F5-8B51-359B282670BAQ55621188-952CC64E-9F4D-453A-9174-83605E486A61Q58708831-607690A5-FE23-47AB-A86D-223448A8F1F7
P2860
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
@en
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
@nl
type
label
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
@en
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
@nl
prefLabel
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
@en
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
@nl
P2093
P2860
P1476
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
@en
P2093
Aliya N Husain
Deborah Lang
Leonardo Faoro
Maria Tretiakova
Philip Cagle
Rajani Kanteti
Sivakumar Loganathan
Soundararajan Krishnaswamy
Todd Kroll
Vidya Nallasura
P2860
P2888
P304
P356
10.1038/LABINVEST.2008.168
P577
2009-01-12T00:00:00Z